Salarius Pharmaceuticals (SLRX) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Salarius Pharmaceuticals's actual EPS was -$3.28, beating the estimate of -$54.67 per share, resulting in a 94.00% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
